참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Benzene | HCID 241 | — |
| 반응물 | Ethanol | HCID 702 | — |
| 반응물 | Methanol | HCID 887 | — |
| 반응물 | Dimethylacetamide | HCID 31374 | — |
| 반응물 | HCID 178482881 | HCID 178482881 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 용매 | Ethyl Acetate | HCID 8857 | — |
| 생성물 | Tricine | HCID 79784 | — |
| 생성물 | HCID 178482881 | HCID 178482881 | — |
반응 단계
Tri-tetracycline complexes of the invention can be identified by chromatography. Minocycline was subjected to thin layer chromatography on a Kieselgel G thin layer plate in a 50:10:10:10:10:10 solvent mixture containing benzene, methanol, ethanol, ethyl acetate, dimethylformamide and dimethylacetamide. Rf of minocycline:0.16, whereas the Rf value of the complex of minocycline formed with N-tris(hydroxymethyl)methylglycine is 0.63. Chelocardin was identified in a similar way, its Rf value in the previous system is 0.21, whereas the Rf value of the complex of chelocardin formed with N-tris(hydroxymethyl)methylglycine is 0.42. The Rf value of minocycline hydrochloride on Kieselgel G thin layer plate in a 60:20:10:10 solvent system of benzene methanol, ethyl acetate and dimethylformamide is 0.1, whereas the Rf value of the complex of minocycline with tris(hydroxymethyl)aminomethane is 0.2.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04418060 |
|---|
| 출처 데이터셋 | uspto-grants-1983_11 |
|---|
| ORD ID | ord-5f60bb9a05054da6bae337f2c3edc479 |
|---|
| 출처 메모 | uspto-grants-1983_11 |
|---|